Výsledky vyhledávání

Background: Reference to so-called real-world data is more often made in marketing authorization applications for medicines intended to diagnose, prevent or treat rare diseases compared to more common diseases. We provide granularity on the type and

Externí odkaz: https://doaj.org/article/fd83b816f1094ecf8facffed53fa472c

Zobrazit plný text záznamu

Akademický článek

Real-World Data and Budget Impact Analysis (BIA): Evaluation of a Targeted Next-Generation Sequencing Diagnostic Approach in Two Orthopedic Rare Diseases

Autor: Elena Pedrini, Antonella Negro, Eugenio Di Brino, Valentina Pecoraro, Camilla Sculco, Elisabetta Abelli, Maria Gnoli, Armando Magrelli, Luca Sangiorgi, Americo Cicchetti

Publikováno v: Frontiers in Pharmacology, Vol 13 (2022)

Objective: Next-generation sequencing (NGS) technology, changing the diagnostic approach, has become essential in clinical settings, and its adoption by public health laboratories is now the practice. Despite this, as technological innovations, its i

Externí odkaz: https://doaj.org/article/de9d6b70313d488cba2dfae16194ea56

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání